Oxygenation in acute exacerbation of interstitial lung disease:a nationwide survey.

Elise Artaud-Macari, Marjolaine Georges, Muriel Fartoukh, Jesus Gonzalez-Bermejo, Christophe Girault, Antoine Cuvelier

Abstract read

In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elise Artaud-MacariDepartment of Pulmonary, Thoracic Oncology and Respiratory Intensive Care, Univ Rouen Normandie, GRHVN UR 3830, CHU Rouen, 76000, Rouen, France. elise.artaud-macari@chu-rouen.fr.ORCID http://orcid.org/0000-0001-7604-6839

Marjolaine GeorgesService de pneumologie et soins intensifs respiratoires, Centre de référence des maladies pulmonaires rares de l'adulte, centre hospitalier universitaire Dijon- Bourgogne, Dijon, France.

Muriel FartoukhService de Médecine Intensive Réanimation, Hôpital Tenon, APHP. Faculté de Médecine Sorbonne Université, Sorbonne Université, Paris, France.

Jesus Gonzalez-BermejoService de Pneumologie et Réanimation Respiratoire, Hôpital de la Pitié- Salpêtrière, Paris, France.

Christophe GiraultDepartment of Medical Intensive Care, Univ Rouen Normandie, CHU Rouen, Rouen, GRHVN UR 3830, F-76000, France.

Antoine CuvelierDepartment of Pulmonary, Thoracic Oncology and Respiratory Intensive Care, Univ Rouen Normandie, GRHVN UR 3830, CHU Rouen, 76000, Rouen, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute exacerbation of interstitial lung disease (AE-ILD) may lead to acute respiratory failure with poor prognosis. Little is known about the optimal oxygenation strategy in this indication, in particular since the development of high-flow nasal oxygen therapy (HFNO). Therefore, we conducted a nationwide survey among respiratory and intensive care unit (ICU) physicians to assess their real-life practices. Between January and June 2024, physicians were questioned, using an online survey (11 questions), regarding the non-invasive oxygenation strategy they used in the management of patients with AE-ILD: face mask (FM), HFNO, continuous positive airway pressure (CPAP) or non-invasive ventilation (NIV). The response rate was 119/270 (44.1%), including 59.5% of ICU and 40.5% of respiratory physicians.=.

Indexed as

Lung Diseases, InterstitialOxygen Inhalation TherapyContinuous Positive Airway PressureFemaleHumansIntensive Care UnitsMaleMiddle AgedNoninvasive VentilationRespiratory InsufficiencySurveys and QuestionnairesAcute exacerbation of interstitial lung diseaseClinical practiceHigh-flow nasal oxygen therapyIntensive careNon-invasive ventilation

Identifiers

PMID41462584

DOI10.1038/s41598-025-30662-6

PMCPMC12783616

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.